Skip to content
News
Careers
News
Careers
Linkedin
Envelope
Our Company
Purpose
Why Us?
Board of Directors
Management
History
Our Offering
Manufacturing
Packaging
New Products
Value-Added Services
Quality
Commercial Services
Sustainability
Contact
Our Company
Purpose
Why Us?
Board of Directors
Management
History
Our Offering
Manufacturing
Packaging
New Products
Value-Added Services
Quality
Commercial Services
Sustainability
Contact
Our Company
Purpose
Why Us?
Board of Directors
Management
History
Our Offering
Manufacturing
Packaging
New Products
Value-Added Services
Quality
Commercial Services
Sustainability
Contact
News
Stay
Updated
31.07.2025
ATACOR RE-LAUNCHED FROM OUR EU-GMP SITE IN LESKOVAC
31.07.2025
DERMIFIN JOINS OUR OTC LINEUP
23.07.2025
Leading The Way: Interview with Sanja Spasojevic, Business Development Director – CDMO
02.04.2025
Strengthening Oncology Treatment Access in the Western Balkans
08.02.2025
Leading The Way: Interview with Snezana Stojilkovic, Quality Director
05.09.2024
Leading The Way: Interview with Dusan Cvetanovic, Senior Site Director
28.08.2024
Frontier Zdravlje Achieves EcoVadis Certification: Top 35% for Global Sustainability
10.07.2024
Frontier Zdravlje Successfully Completes European Medicines Authority Inspection
28.12.2023
Frontier Zdravlje and BIO4 Campus: Shaping the Future of Biotech
15.12.2023
Frontier Zdravlje receives jubilee award from the Chamber of Commerce for 70 years of excellence
25.11.2023
Frontier Zdravlje celebrates 70 years of successful business
10.11.2023
Frontier Zdravlje expands EU presence with PazoFront® authorization in Bulgaria
19.10.2023
CEO’s Announcement on the Biotech Future Forum in Belgrade
08.09.2023
Frontier Biopharma Signs Landmark MoU with SK Bioscience and Government of Serbia to Establish a European Vaccines Development and Manufacturing Hub in Serbia
18.04.2023
Vishal Kumar Gupta appointed as Group Chief Financial Officer (CFO)
03.04.2023
Latest Project: The signing of a license agreement with the MPP
18.01.2023
Cape Town-based biotechnology company, Afrigen, appoints new board chair
27.12.2022
Frontier Zdravlje and Adalvo Sign Licensing & Supply Agreement for Central & Eastern Europe
13.12.2022
Frontier Zdravlje Awarded for Successful Business in 2022 by the Chamber of Commerce and Industry of Serbia
29.09.2022
Frontier Zdravlje at “Serbia Business Run” in Belgrade
01.09.2022
Tsvetomir Yordanov joins Frontier Zdravlje as Group Business Development Director
18.08.2022
Frontier Zdravlje receives an EU Wholesale Distribution Authorization by BDA
17.08.2022
The ALIMS Approves Regkirona for Serbia with Frontier Zdravlje as MA Holder
17.08.2022
Frontier Zdravlje Signs License Agreement with Medicines Patent Pool for nirmatrelvir
21.07.2022
Successful visit supporting the World Pharmacy Students Exchange Program
07.03.2022
Tamara Vasojevic joins Frontier Zdravlje as Group Human Resources Director
20.12.2021
Zdravlje continues with “Cap for Handicap”
22.10.2021
Frontier Zdravlje Announces Partnership with Celltrion Healthcare for Monoclonal Antibody COVID-19 Treatment
17.09.2021
Zdravlje Expands Global Footprint
24.08.2021
Leskovac Tandem with Zdravlje at the Paralympic Games in Tokyo
25.06.2021
Zdravlje Leskovac – Green Energy for Cleaner Environment and Sustainable Growth
28.05.2021
Zdravlje at JUSK’s VI Annual International Conference
20.05.2021
Marko Matovic, Graduated Lawyer, appointed as Legal Affairs Manager in Zdravlje AD
01.04.2021
Frontier Pharma and Baystone Group completes its acquisition of Zdravlje